Miriam Puttini

975 total citations
8 papers, 446 citations indexed

About

Miriam Puttini is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Miriam Puttini has authored 8 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 3 papers in Rheumatology. Recurrent topics in Miriam Puttini's work include Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Miriam Puttini is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Miriam Puttini collaborates with scholars based in Italy, Canada and Switzerland. Miriam Puttini's co-authors include Carlo Gambacorti‐Passerini, Franca Formelli, Sara Redaelli, Loredana Cleris, Léonardo Scapozza, Arianna Donella‐Deana, Rocco Piazza, Edoardo Marchesi, Federica Andreoni and Frank Boschelli and has published in prestigious journals such as Blood, Cancer Research and Leukemia.

In The Last Decade

Miriam Puttini

8 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miriam Puttini Italy	7	260	200	134	134	87	8	446
Roberta Rostagno Italy	5	284 1.1×	227 1.1×	121 0.9×	142 1.1×	93 1.1×	6	464
Adriana Puma Italy	12	163 0.6×	140 0.7×	141 1.1×	51 0.4×	93 1.1×	22	452
Sandra Di Gregorio Italy	10	109 0.4×	101 0.5×	108 0.8×	41 0.3×	66 0.8×	17	323
Susanne Isfort Germany	10	164 0.6×	202 1.0×	149 1.1×	65 0.5×	40 0.5×	40	346
Jeffrey Keats United States	8	165 0.6×	118 0.6×	185 1.4×	92 0.7×	156 1.8×	12	402
Alice Huntsman Labed United States	4	55 0.2×	70 0.3×	112 0.8×	161 1.2×	27 0.3×	6	433
Christine Flefleh United States	9	139 0.5×	104 0.5×	111 0.8×	80 0.6×	159 1.8×	13	409
Pekka Anttila Finland	12	261 1.0×	132 0.7×	244 1.8×	36 0.3×	129 1.5×	31	404
Giuseppina Fugazza Italy	13	330 1.3×	226 1.1×	230 1.7×	83 0.6×	61 0.7×	36	599
E. Nadal Spain	13	388 1.5×	140 0.7×	207 1.5×	44 0.3×	162 1.9×	18	587

Countries citing papers authored by Miriam Puttini

Since Specialization

Citations

This map shows the geographic impact of Miriam Puttini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Puttini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Puttini more than expected).

Fields of papers citing papers by Miriam Puttini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Puttini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Puttini. The network helps show where Miriam Puttini may publish in the future.

Co-authorship network of co-authors of Miriam Puttini

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Puttini. A scholar is included among the top collaborators of Miriam Puttini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Puttini. Miriam Puttini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Puttini, Miriam, Sara Redaelli, Rosalind H. Gunby, et al.. (2008). Characterization of compound 584, an Abl kinase inhibitor with lasting effects. Haematologica. 93(5). 653–661. 7 indexed citations

2.

Gunby, Rosalind H., Elisa Sala, Carmen Julia Tartari, et al.. (2007). Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 7(6). 594–611. 26 indexed citations

3.

Galietta, Annamaria, Rosalind H. Gunby, Sara Redaelli, et al.. (2007). NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma. Blood. 110(7). 2600–2609. 32 indexed citations

4.

Mologni, Luca, Elisa Sala, Sara Cazzaniga, et al.. (2006). Inhibition of RET tyrosine kinase by SU5416. Journal of Molecular Endocrinology. 37(2). 199–212. 51 indexed citations

5.

Puttini, Miriam, Addolorata Maria Luce Coluccia, Frank Boschelli, et al.. (2006). In vitro and In vivo Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells. Cancer Research. 66(23). 11314–11322. 294 indexed citations

6.

Puttini, Miriam, Addolorata Maria Luce Coluccia, Frank Boschelli, et al.. (2006). In Vitro and In Vivo Activity of SKI-606, a Novel Abl/Src Inhibitor, Against Imatinib Resistant BCR-ABL+ Neoplastic Cells.. Blood. 108(11). 2176–2176. 3 indexed citations

7.

Ruchatz, Holger, Miriam Puttini, Loredana Cleris, et al.. (2003). Effect of imatinib on haematopoietic recovery following idarubicin exposure. Leukemia. 17(2). 298–304. 7 indexed citations

8.

Montanari, G, A Bondioli, G Rizzato, et al.. (1992). Treatment with low dose metformin in patients with peripheral vascular disease. Pharmacological Research. 25(1). 63–73. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact